| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |